Laboratory Net Worth
Laboratory Net Worth Breakdown | LH |
Laboratory Net Worth Analysis
Laboratory's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Laboratory's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Laboratory's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Laboratory's net worth analysis. One common approach is to calculate Laboratory's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Laboratory's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Laboratory's net worth. This approach calculates the present value of Laboratory's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Laboratory's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Laboratory's net worth. This involves comparing Laboratory's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Laboratory's net worth relative to its peers.
Enterprise Value |
|
To determine if Laboratory is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Laboratory's net worth research are outlined below:
| Laboratory has a strong financial position based on the latest SEC filings | |
| Over 95.0% of the company shares are owned by institutional investors | |
| On 13th of December 2024 Laboratory paid $ 0.72 per share dividend to its current shareholders | |
| Latest headline from prnewswire.com: Vardas Second Mission, W-2, Launches with Payloads from Air Force Research Laboratory and NASA |
Laboratory Quarterly Good Will |
|
Laboratory uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Laboratory of. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Laboratory's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 15th of February 2024 Upcoming Quarterly Report | View | |
| 23rd of April 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 15th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Laboratory Target Price Consensus
Laboratory target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Laboratory's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 19 | Strong Buy |
Most Laboratory analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Laboratory stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Laboratory, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationLaboratory Target Price Projection
Laboratory's current and average target prices are 238.56 and 261.36, respectively. The current price of Laboratory is the price at which Laboratory of is currently trading. On the other hand, Laboratory's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Laboratory Market Quote on 18th of January 2025
Target Price
Analyst Consensus On Laboratory Target Price
Know Laboratory's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Laboratory is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Laboratory of backward and forwards among themselves. Laboratory's institutional investor refers to the entity that pools money to purchase Laboratory's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Amvescap Plc. | 2024-09-30 | 1.3 M | Veritas Investment Partners (uk) Ltd. | 2024-09-30 | 1.2 M | Bank Of America Corp | 2024-09-30 | 1.1 M | Norges Bank | 2024-06-30 | 1 M | Northern Trust Corp | 2024-09-30 | 1 M | Nordea Investment Mgmt Bank Demark A/s | 2024-09-30 | 984 K | Cooke & Bieler Lp | 2024-09-30 | 942.1 K | Ubs Asset Mgmt Americas Inc | 2024-09-30 | 914 K | American Century Companies Inc | 2024-09-30 | 826 K | Vanguard Group Inc | 2024-09-30 | 9.6 M | Blackrock Inc | 2024-09-30 | 9.2 M |
Follow Laboratory's market capitalization trends
The company currently falls under 'Large-Cap' category with a market capitalization of 19.97 B.Market Cap |
|
Project Laboratory's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.05 | 0.05 | |
| Return On Capital Employed | 0.06 | 0.06 | |
| Return On Assets | 0.03 | 0.03 | |
| Return On Equity | 0.06 | 0.06 |
When accessing Laboratory's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Laboratory's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Laboratory's profitability and make more informed investment decisions.
Evaluate Laboratory's management efficiency
Laboratory has Return on Asset (ROA) of 0.0396 % which means that for every $100 of assets, it generated a profit of $0.0396. This is way below average. Likewise, it shows a return on total equity (ROE) of 0.0543 %, which means that it produced $0.0543 on every 100 dollars invested by current stockholders. Laboratory's management efficiency ratios could be used to measure how well Laboratory manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to 0.05. The current Return On Capital Employed is estimated to decrease to 0.06. As of now, Laboratory's Other Current Assets are increasing as compared to previous years. The Laboratory's current Total Current Assets is estimated to increase to about 4.5 B, while Intangible Assets are projected to decrease to under 2 B.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 81.53 | 85.61 | |
| Tangible Book Value Per Share | (21.05) | (22.10) | |
| Enterprise Value Over EBITDA | 21.49 | 10.82 | |
| Price Book Value Ratio | 2.89 | 3.28 | |
| Enterprise Value Multiple | 21.49 | 10.82 | |
| Price Fair Value | 2.89 | 3.28 | |
| Enterprise Value | 7.4 B | 7.8 B |
Examining the leadership quality of Laboratory of offers valuable insights into its operational efficiency and financial health. This analysis assists investors in making informed decisions regarding the stock.
Enterprise Value Revenue 2.0587 | Revenue | Quarterly Revenue Growth 0.074 | Revenue Per Share | Return On Equity |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Laboratory insiders, such as employees or executives, is commonly permitted as long as it does not rely on Laboratory's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Laboratory insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Laboratory Corporate Filings
8K | 10th of January 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 8th of January 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F3 | 3rd of December 2024 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
10Q | 29th of October 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
Laboratory Earnings Estimation Breakdown
The calculation of Laboratory's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Laboratory is estimated to be 3.628575 with the future projection ranging from a low of 3.5921 to a high of 3.65. Please be aware that this consensus of annual earnings estimates for Laboratory of is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
3.59 Lowest | Expected EPS | 3.65 Highest |
Laboratory Earnings Projection Consensus
Suppose the current estimates of Laboratory's value are higher than the current market price of the Laboratory stock. In this case, investors may conclude that Laboratory is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Laboratory's stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of December 2024 | Current EPS (TTM) | |
| 19 | 97.0% | 3.5 | 3.628575 | 5.28 |
Laboratory Earnings History
Earnings estimate consensus by Laboratory analysts from Wall Street is used by the market to judge Laboratory's stock performance. Investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we recommend analyzing not only Laboratory's upcoming profit reports and earnings-per-share forecasts but also comparing them to our different valuation methods.Laboratory Quarterly Gross Profit |
|
Laboratory Earnings per Share Projection vs Actual
Actual Earning per Share of Laboratory refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Laboratory of predict the company's earnings will be in the future. The higher the earnings per share of Laboratory, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.Laboratory Estimated Months Earnings per Share
For an investor who is primarily interested in generating an income out of investing in entities such as Laboratory, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Laboratory should always be considered in relation to other companies to make a more educated investment decision.Laboratory Quarterly Analyst Estimates and Surprise Metrics
Earnings surprises can significantly impact Laboratory's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-10-24 | 2024-09-30 | 3.48 | 3.5 | 0.02 | 0 | ||
2024-07-25 | 2024-06-30 | 3.8 | 3.94 | 0.14 | 3 | ||
2024-04-25 | 2024-03-31 | 3.48 | 3.68 | 0.2 | 5 | ||
2024-02-15 | 2023-12-31 | 3.26 | 3.3 | 0.04 | 1 | ||
2023-10-26 | 2023-09-30 | 3.33 | 3.38 | 0.05 | 1 | ||
2023-07-27 | 2023-06-30 | 3.53 | 3.8 | 0.27 | 7 | ||
2023-04-25 | 2023-03-31 | 3.96 | 3.82 | -0.14 | 3 | ||
2023-02-16 | 2022-12-31 | 4.1 | 4.14 | 0.04 | 0 | ||
2022-10-27 | 2022-09-30 | 4.67 | 4.68 | 0.01 | 0 | ||
2022-07-28 | 2022-06-30 | 4.7 | 4.95 | 0.25 | 5 | ||
2022-04-28 | 2022-03-31 | 5.98 | 6.11 | 0.13 | 2 | ||
2022-02-10 | 2021-12-31 | 5.8 | 6.77 | 0.97 | 16 | ||
2021-10-28 | 2021-09-30 | 4.92 | 6.82 | 1.9 | 38 | ||
2021-07-29 | 2021-06-30 | 5.53 | 6.13 | 0.6 | 10 | ||
2021-04-29 | 2021-03-31 | 7.43 | 8.79 | 1.36 | 18 | ||
2021-02-11 | 2020-12-31 | 8.11 | 10.56 | 2.45 | 30 | ||
2020-10-27 | 2020-09-30 | 5.31 | 8.41 | 3.1 | 58 | ||
2020-07-28 | 2020-06-30 | 1 | 2.57 | 1.57 | 157 | ||
2020-04-29 | 2020-03-31 | 1.95 | 2.37 | 0.42 | 21 | ||
2020-02-13 | 2019-12-31 | 2.8 | 2.86 | 0.06 | 2 | ||
2019-10-24 | 2019-09-30 | 2.85 | 2.9 | 0.05 | 1 | ||
2019-07-25 | 2019-06-30 | 2.92 | 2.93 | 0.01 | 0 | ||
2019-04-30 | 2019-03-31 | 2.53 | 2.62 | 0.09 | 3 | ||
2019-02-07 | 2018-12-31 | 2.49 | 2.52 | 0.03 | 1 | ||
2018-10-24 | 2018-09-30 | 2.88 | 2.84 | -0.04 | 1 | ||
2018-07-25 | 2018-06-30 | 2.93 | 2.98 | 0.05 | 1 | ||
2018-04-25 | 2018-03-31 | 2.63 | 2.78 | 0.15 | 5 | ||
2018-02-06 | 2017-12-31 | 2.38 | 2.45 | 0.07 | 2 | ||
2017-10-25 | 2017-09-30 | 2.39 | 2.46 | 0.07 | 2 | ||
2017-07-26 | 2017-06-30 | 2.4 | 2.47 | 0.07 | 2 | ||
2017-04-25 | 2017-03-31 | 2.2 | 2.22 | 0.02 | 0 | ||
2017-02-16 | 2016-12-31 | 2.13 | 2.15 | 0.02 | 0 | ||
2016-10-26 | 2016-09-30 | 2.29 | 2.25 | -0.04 | 1 | ||
2016-07-27 | 2016-06-30 | 2.3 | 2.31 | 0.01 | 0 | ||
2016-04-25 | 2016-03-31 | 1.96 | 2.02 | 0.06 | 3 | ||
2016-02-18 | 2015-12-31 | 1.99 | 1.98 | -0.01 | 0 | ||
2015-10-26 | 2015-09-30 | 2.06 | 2.07 | 0.01 | 0 | ||
2015-07-28 | 2015-06-30 | 2.03 | 2.09 | 0.06 | 2 | ||
2015-04-27 | 2015-03-31 | 1.63 | 1.73 | 0.1 | 6 | ||
2015-02-20 | 2014-12-31 | 1.63 | 1.65 | 0.02 | 1 | ||
2014-10-28 | 2014-09-30 | 1.75 | 1.8 | 0.05 | 2 | ||
2014-07-18 | 2014-06-30 | 1.77 | 1.78 | 0.01 | 0 | ||
2014-04-28 | 2014-03-31 | 1.58 | 1.51 | -0.07 | 4 | ||
2014-02-07 | 2013-12-31 | 1.66 | 1.61 | -0.05 | 3 | ||
2013-10-18 | 2013-09-30 | 1.8 | 1.8 | 0.0 | 0 | ||
2013-07-19 | 2013-06-30 | 1.8 | 1.8 | 0.0 | 0 | ||
2013-04-19 | 2013-03-31 | 1.76 | 1.74 | -0.02 | 1 | ||
2013-02-08 | 2012-12-31 | 1.62 | 1.63 | 0.01 | 0 | ||
2012-10-18 | 2012-09-30 | 1.74 | 1.76 | 0.02 | 1 | ||
2012-07-19 | 2012-06-30 | 1.77 | 1.77 | 0.0 | 0 | ||
2012-04-19 | 2012-03-31 | 1.67 | 1.74 | 0.07 | 4 | ||
2012-02-10 | 2011-12-31 | 1.53 | 1.56 | 0.03 | 1 | ||
2011-10-20 | 2011-09-30 | 1.6 | 1.61 | 0.01 | 0 | ||
2011-07-21 | 2011-06-30 | 1.63 | 1.64 | 0.01 | 0 | ||
2011-04-21 | 2011-03-31 | 1.46 | 1.52 | 0.06 | 4 | ||
2011-02-10 | 2010-12-31 | 1.31 | 1.34 | 0.03 | 2 | ||
2010-10-21 | 2010-09-30 | 1.4 | 1.47 | 0.07 | 5 | ||
2010-07-22 | 2010-06-30 | 1.42 | 1.46 | 0.04 | 2 | ||
2010-04-21 | 2010-03-31 | 1.31 | 1.3 | -0.01 | 0 | ||
2010-02-11 | 2009-12-31 | 1.15 | 1.16 | 0.01 | 0 | ||
2009-10-22 | 2009-09-30 | 1.15 | 1.22 | 0.07 | 6 | ||
2009-07-23 | 2009-06-30 | 1.27 | 1.3 | 0.03 | 2 | ||
2009-04-23 | 2009-03-31 | 1.17 | 1.22 | 0.05 | 4 | ||
2009-02-12 | 2008-12-31 | 1.09 | 1.1 | 0.01 | 0 | ||
2008-10-23 | 2008-09-30 | 1.12 | 1.1 | -0.02 | 1 | ||
2008-07-24 | 2008-06-30 | 1.24 | 1.24 | 0.0 | 0 | ||
2008-04-24 | 2008-03-31 | 1.14 | 1.14 | 0.0 | 0 | ||
2008-02-07 | 2007-12-31 | 1.01 | 1.04 | 0.03 | 2 | ||
2007-10-25 | 2007-09-30 | 1.09 | 1.07 | -0.02 | 1 | ||
2007-07-24 | 2007-06-30 | 1.09 | 1.09 | 0.0 | 0 | ||
2007-04-26 | 2007-03-31 | 0.93 | 0.98 | 0.05 | 5 | ||
2007-02-15 | 2006-12-31 | 0.72 | 0.85 | 0.13 | 18 | ||
2006-10-24 | 2006-09-30 | 0.8 | 0.84 | 0.04 | 5 | ||
2006-07-25 | 2006-06-30 | 0.83 | 0.87 | 0.04 | 4 | ||
2006-04-25 | 2006-03-31 | 0.74 | 0.76 | 0.02 | 2 | ||
2006-02-16 | 2005-12-31 | 0.65 | 0.67 | 0.02 | 3 | ||
2005-10-20 | 2005-09-30 | 0.72 | 0.7 | -0.02 | 2 | ||
2005-07-21 | 2005-06-30 | 0.75 | 0.76 | 0.01 | 1 | ||
2005-04-19 | 2005-03-31 | 0.65 | 0.67 | 0.02 | 3 | ||
2005-02-15 | 2004-12-31 | 0.61 | 0.61 | 0.0 | 0 | ||
2004-10-21 | 2004-09-30 | 0.66 | 0.66 | 0.0 | 0 | ||
2004-07-22 | 2004-06-30 | 0.66 | 0.7 | 0.04 | 6 | ||
2004-04-22 | 2004-03-31 | 0.59 | 0.61 | 0.02 | 3 | ||
2004-02-12 | 2003-12-31 | 0.53 | 0.53 | 0.0 | 0 | ||
2003-10-23 | 2003-09-30 | 0.59 | 0.59 | 0.0 | 0 | ||
2003-07-22 | 2003-06-30 | 0.6 | 0.6 | 0.0 | 0 | ||
2003-04-28 | 2003-03-31 | 0.49 | 0.51 | 0.02 | 4 | ||
2003-02-18 | 2002-12-31 | 0.36 | 0.36 | 0.0 | 0 | ||
2002-10-30 | 2002-09-30 | 0.44 | 0.46 | 0.02 | 4 | ||
2002-07-24 | 2002-06-30 | 0.54 | 0.55 | 0.01 | 1 | ||
2002-04-22 | 2002-03-31 | 0.46 | 0.47 | 0.01 | 2 | ||
2002-02-13 | 2001-12-31 | 0.27 | 0.29 | 0.02 | 7 | ||
2001-10-22 | 2001-09-30 | 0.34 | 0.37 | 0.03 | 8 | ||
2001-07-23 | 2001-06-30 | 0.35 | 0.37 | 0.02 | 5 | ||
2001-04-23 | 2001-03-31 | 0.31 | 0.31 | 0.0 | 0 | ||
2001-02-14 | 2000-12-31 | 0.15 | 0.08 | -0.07 | 46 | ||
2000-10-23 | 2000-09-30 | 0.2 | 0.24 | 0.04 | 20 | ||
2000-07-19 | 2000-06-30 | 0.22 | 0.24 | 0.02 | 9 | ||
2000-04-24 | 2000-03-31 | 0.11 | 0.18 | 0.07 | 63 | ||
1999-10-20 | 1999-09-30 | 0.08 | 0.08 | 0.0 | 0 | ||
1999-07-22 | 1999-06-30 | 0.13 | 0.15 | 0.02 | 15 | ||
1999-04-22 | 1999-03-31 | 0.05 | 0.05 | 0.0 | 0 | ||
1999-02-23 | 1998-12-31 | -0.02 | -0.28 | -0.26 | 1300 | ||
1998-10-27 | 1998-09-30 | -0.02 | 0.002 | 0.022 | 110 | ||
1998-07-21 | 1998-06-30 | -0.04 | 0.03 | 0.07 | 175 | ||
1998-04-30 | 1998-03-31 | -0.1 | -0.02 | 0.08 | 80 | ||
1998-03-17 | 1997-12-31 | -0.12 | -0.1 | 0.02 | 16 | ||
1997-10-28 | 1997-09-30 | -0.07 | -0.12 | -0.05 | 71 | ||
1997-07-29 | 1997-06-30 | 0.06 | 0.05 | -0.01 | 16 | ||
1997-04-25 | 1997-03-31 | 0.1 | 0.05 | -0.05 | 50 | ||
1997-02-20 | 1996-12-31 | 0 | 0.03 | 0.03 | 0 | ||
null | null | null | null | null | 0 | ||
1996-08-01 | 1996-06-30 | 0.32 | 0.13 | -0.19 | 59 | ||
1996-04-25 | 1996-03-31 | 0.19 | 0.13 | -0.06 | 31 | ||
1996-02-12 | 1995-12-31 | 0.38 | 0.18 | -0.2 | 52 | ||
1995-10-24 | 1995-09-30 | 0.3 | 0.3 | 0.0 | 0 |
Laboratory Corporate Directors
| Kerrii Anderson | Independent Director | Profile | |
| JeanLuc Belingard | Independent Director | Profile | |
| Peter Neupert | Lead Independent Director | Profile | |
| Richelle Parham | Independent Director | Profile |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Laboratory of. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Laboratory. If investors know Laboratory will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Laboratory listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.05) | Dividend Share 2.88 | Earnings Share 5.28 | Revenue Per Share | Quarterly Revenue Growth 0.074 |
The market value of Laboratory is measured differently than its book value, which is the value of Laboratory that is recorded on the company's balance sheet. Investors also form their own opinion of Laboratory's value that differs from its market value or its book value, called intrinsic value, which is Laboratory's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Laboratory's market value can be influenced by many factors that don't directly affect Laboratory's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Laboratory's value and its price as these two are different measures arrived at by different means. Investors typically determine if Laboratory is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Laboratory's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.